Right at 16.80's Adam Frankenstein released this, and TKMR came tumbling down:
The Tekmira Ebola Trade May Already Be Over
By: Adam Feuerstein | 08/04/14 - 10:07 AM EDT
If this CNN story is true, traders playing the Ebola scare by buying Tekmira Pharmaceuticals (TKMR) picked the wrong horse. Mapp Biopharmaceuticals, a privately held drug company in San Diego, might already have an effective therapy against the deadly virus racing through Africa.
CNN is reporting that the two U.S. aid workers infected with Ebola were treated -- and their lives saved while still in Africa -- with an experimental drug known as ZMapp developed by Mapp Biopharma. The drug had never been tried on humans before but had shown promise in animal studies, CNN reports.
News 
Market Data 
Discover 
